Lepto

28 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

1430.0%

Death Rate

Active Ingredients

Lepto

Administration Routes

SubcutaneousUnknown

Species Affected

Dog 28

Most Affected Breeds

Crossbred Canine/dog 5

Retriever - Golden 4

Retriever - Labrador 3

Terrier - Cairn 2

Pug 2

Shiba Inu 1

Spaniel - King Charles Cavalier 1

Bulldog - French 1

Chihuahua 1

Boxer (German Boxer) 1

Most Reported Reactions

Emesis (multiple) 5

Lethargy (see also Central nervous system depression in Neurological) 5

Diarrhoea 4

Not eating 4

Death 3

Lethargy (see also Central nervous system depression in 'Neurological') 3

Emesis 3

Anorexia 2

Application site pain 2

Facial swelling (see also 'Skin') 2

Fever 2

Facial swelling (see also Skin) 2

Outcome Breakdown

Ongoing

11 (39.3%)

Recovered/Normal

8 (28.6%)

Outcome Unknown

5 (17.9%)

Died

3 (10.7%)

Euthanized

1 (3.6%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.